Work

Pre-clinical analysis of fluvastatin as a metastasis-prevention agent in breast cancer

Year: 2017
Type: dissertation
Abstract: Fluvastatin is a member of the statin family of drugs, widely prescribed to lower serum cholesterol. Accumulating evidence from epidemiological, pre-clinical, and clinical studies indicate that statins have pleiotropic anti-cancer activities. Previous work have suggested a mechanistic model where depletion of farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP), and consequently inhibition of prenylation of RAS family members, underlies statin-induced cancer cell death. However, several lines of evidence suggest that this model is incomplete, yet alternative mechanisms have not been described. The purpose of this thesis is to (i) elucidate the molecular mechanism of fluvastatin sensitivity in breast cancer cells, and (ii) identify the point of therapeutic intervention in which fluvastatin treatment will provide clinical benefit in breast cancer patients. We first demonstrate that fluvastatin-induced cell death can be uncoupled from inhibition of protein prenylation, in breast cancer cells that have undergone epithelial-mesenchymal transition (EMT). In these cells, the mechanism of fluvastatin sensitivity is an increased dependency on the biosynthesis of dolichol, required for co-translational protein N-glycosylation. Fluvastatin treatment impairs the expression of tri- and tetra-antennary β1,6-branched complex type N-glycans associated with breast cancer cell EMT and metastasis. These results, along with supporting evidence from epidemiological studies, provided rationale to examine the efficacy of fluvastatin as a metastasis-prevention agent in breast cancer. Using a mouse model of post-surgical metastatic breast cancer that fully recapitulates the intravasation and dissemination process, we show that fluvastatin treatment in the adjuvant setting significantly delays breast cancer metastasis, reduces metastatic burden, and improves overall survival. Overall, this research provides novel insight into the mechanism of the anti-cancer effects of fluvastatin, and demonstrates efficacy of fluvastatin use in the adjuvant therapeutic setting to prevent breast cancer metastasis.
Author: Rosemary Yu
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W2964518611
Cites: 301
Cited by: 1
Related to: 10